Výsledky vyhledávání - "I. Sviezhentseva"

Akademický článek

Features of the etythropoesis upon treatment of chronic myeloid leukemia with tyrosine kinase inhibitor

Autor: I. Sviezhentseva, D. Bilko, N. Bilko, I. Dyagil

Publikováno v: Vìsnik: Kiïvsʹkij Nacìonalʹnij Unìversitet Imenì Tarasa Ševčenka. Bìologìâ, Vol 68, Iss 3, Pp 51-54 (2016)

A functional activity of erythroid hematopoietic cells of patients with chronic myeloid leukemia, who were treated with tyrosine kinase inhibitor of the first and second generation was investigated. Samples of bone marrow of patients with resistance

Externí odkaz: https://doaj.org/article/3d4d5e81efa748c3acde2599828c94d4

Zobrazit plný text záznamu

Сharacteristics of proliferation and differentiation of erythroid progenitor cells at chronic myeloid Leukemia in cells culture in vivo

Autor: Iryna Dyagil, Denys bilko, I. Sviezhentseva, Nadiia Bilko

Publikováno v: Bulletin of Taras Shevchenko National University of Kyiv. Series: Problems of Physiological Functions Regulation. 20:65-68

The article presents a study of proliferation and differentiation features of erythroid progenitor cells of patients with chronic myeloid leukemia during the treatment with tyrosine kinase inhibitors – imatinib and nilotinib. The cultivation result

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a5e3409280548d2e7b2666673f8d95e1
https://doi.org/10.17721/2616_6410.2016.20.65-68

Zobrazit plný text záznamu

PF402 PECULIARITIES OF THE EXPRESSION OF KI-67 AND CD34 HEMOPOIETIC PRECURSOR CELLS IN PB AND BM OF CML PATIENTS WITH THE DIFFERENT RESPONSES TO IMATINIB AND NILOTINIB THERAPY

Autor: I. Sviezhentseva, T. Perekhrestenko, U. Melnyk, I. Dyagil

Publikováno v: HemaSphere. 3:153

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4129b5f3bba282b804a2eda0da1f15e8
https://doi.org/10.1097/01.hs9.0000559820.77165.80

Zobrazit plný text záznamu

Mechanisms of resistance in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors

Autor: T, Perekhrestenko, M, Diachenko, I, Sviezhentseva, A, Gordienko, D, Bilko

Publikováno v: Georgian medical news. (240)

Up to date, two major mechanisms have been proposed as an explanation for myeloid cells expansion in chronic myeloid leukemia (CML). One is a reduced susceptibility of hematopoietic stem or progenitor cells to apoptosis, while the other one is an inc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0dab7cecfb26323f14b5d5d09692f505
https://pubmed.ncbi.nlm.nih.gov/25879558

Zobrazit plný text záznamu

Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy

Autor: M. V. Diachenko, Denys bilko, Iryna Dyagil, T. Perekhrestenko, A I Gordienko, I. Sviezhentseva

Publikováno v: Scopus-Elsevier

Introduction: It is believed that the reason of the leukemic clone cell resistance to treatment with tyrosine kinase inhibitors during chronic myeloid leukemia (CML) is mutations in the genome of an early bone marrow progenitor cells that are CD34-po

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ed38c285ffdd9387f0e312a9758b06
http://dspace.nbuv.gov.ua/handle/123456789/145458

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání